What are the benefits and harms of antimetabolites (mitomycin C [MMC] and 5-fluorouracil [5-FU]) as an adjunct to dacryocystorhinostomy (DCR) for people with nasolacrimal duct obstruction?
Year: 2020
Type: article
Source: Cochrane Clinical Answers
DOI: 10.1002/cca.3129
Author: Sarah Anderson
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3049086307